Gary J Brenner

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 5

Top Topics

Top Venues

Journal of clinical medicine

Antioxidants (Basel, Switzerland)

International journal of molecular sciences

Human vaccines & immunotherapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Sherif G Ahmed, Giulia Oliva, Manlin Shao, John J Mekalanos, Gary J Brenner
Culture of attenuated Salmonella Typhimurium VNP20009 in animal-product-free media does not alter schwannoma growth control. Human vaccines & immunotherapeutics 19 (2) (2023)
Krishna Bommakanti, Richard Seist, Phanidhar Kukutla, Murat Cetinbas, Shelley Batts, Ruslan I Sadreyev, Anat Stemmer-Rachamimov, Gary J Brenner, Konstantina M Stankovic
Comparative Transcriptomic Analysis of Archival Human Vestibular Schwannoma Tissue from Patients with and without Tinnitus. Journal of clinical medicine 12 (7) (2023)
Mariko Ezaka, Eizo Marutani, Yusuke Miyazaki, Eiki Kanemaru, Martin K Selig, Sophie L Boerboom, Katrina F Ostrom, Anat Stemmer-Rachamimov, Donald B Bloch, Gary J Brenner, Etsuo Ohshima, Fumito Ichinose
Oral Administration of Glutathione Trisulfide Increases Reactive Sulfur Levels in Dorsal Root Ganglion and Ameliorates Paclitaxel-Induced Peripheral Neuropathy in Mice. Antioxidants (Basel, Switzerland) 11 (11) (2022)
Sherif G Ahmed, Casey A Maguire, Shiliang Alice Cao, Gary J Brenner
Schwannoma Gene Therapy via Adeno-Associated Viral Vector Delivery of Apoptosis-Associated Speck-like Protein Containing CARD (ASC): Preclinical Efficacy and Safety. International journal of molecular sciences 23 (2) (2022)
Phanidhar Kukutla, Sherif G Ahmed, Daniel M DuBreuil, Ahmed Abdelnabi, Murat Cetinbas, Giulia Fulci, Berent Aldikacti, Anat Stemmer-Rachamimov, Scott R Plotkin, Brian Wainger, Ruslan I Sadreyev, Gary J Brenner
Transcriptomic signature of painful human neurofibromatosis type 2 schwannomas. Annals of clinical and translational neurology 8 (7) (2021)